title: An evolutionary conserved region (ECR) in the human dopamine receptor D4 gene supports reporter gene expression in primary cultures derived from the rat cortex.
abstract: BACKGROUND
  Detecting functional variants contributing to diversity of behaviour is crucial for dissecting genetics of complex behaviours. At a molecular level, characterisation of variation in exons has been studied as they are easily identified in the current genome annotation although the functional consequences are less well understood; however, it has been difficult to prioritise regions of non-coding DNA in which genetic variation could also have significant functional consequences. Comparison of multiple vertebrate genomes has allowed the identification of non-coding evolutionary conserved regions (ECRs), in which the degree of conservation can be comparable with exonic regions suggesting functional significance.
  
  
  RESULTS
  We identified ECRs at the dopamine receptor D4 gene locus, an important gene for human behaviours. The most conserved non-coding ECR (D4ECR1) supported high reporter gene expression in primary cultures derived from neonate rat frontal cortex. Computer aided analysis of the sequence of the D4ECR1 indicated the potential transcription factors that could modulate its function. D4ECR1 contained multiple consensus sequences for binding the transcription factor Sp1, a factor previously implicated in DRD4 expression. Co-transfection experiments demonstrated that overexpression of Sp1 significantly decreased the activity of the D4ECR1 in vitro.
  
  
  CONCLUSIONS
  Bioinformatic analysis complemented by functional analysis of the DRD4 gene locus has identified a) a strong enhancer that functions in neurons and b) a transcription factor that may modulate the function of that enhancer.
authors: Institute of Translational Medicine, University of Liverpool, Ashton Street, Liverpool, L69 3GE, UK.
authors: Ursula M
authors: UM
authors: Paredes
authors: Vivien J
authors: VJ
authors: Bubb
authors: Kate
authors: K
authors: Haddley
authors: Gabriele A
authors: GA
authors: Macho
authors: John P
authors: JP
authors: Quinn
references: Mol Immunol. 1989 Oct;26(10):1007-10
references: 2512480
references: Neuropeptides. 2004 Feb;38(1):1-15
references: 15003710
references: Am J Psychiatry. 2003 Apr;160(4):671-6
references: 12668354
references: Mol Psychiatry. 2006 Apr;11(4):323, 410-21
references: 16402133
references: Nature. 2003 Oct 30;425(6961):917-25
references: 14586460
references: Nature. 1991 Apr 18;350(6319):610-4
references: 1840645
references: Biochem Biophys Res Commun. 1997 Jun 18;235(2):321-6
references: 9199190
references: Int J Dev Neurosci. 2000 Feb;18(1):29-37
references: 10708903
references: J Neurochem. 2005 Apr;93(2):474-82
references: 15816870
references: Eur J Neurosci. 2006 Nov;24(9):2429-38
references: 17100831
references: Brain Res Dev Brain Res. 1995 Dec 21;90(1-2):180-3
references: 8719342
references: Peptides. 2004 Nov;25(11):1951-7
references: 15501527
references: Pharmacogenomics J. 2003;3(6):343-8
references: 14581929
references: Curr Med Chem. 2004 Apr;11(8):1023-9
references: 15078164
references: Mol Biol Evol. 2004 Nov;21(11):2116-21
references: 15282332
references: Exp Toxicol Pathol. 2002 Feb;53(6):461-8
references: 11926288
references: J Neural Transm Park Dis Dement Sect. 1995;10(2-3):107-13
references: 9620058
references: Genome Res. 2006 Jul;16(7):855-63
references: 16769978
references: J Neurochem. 1990 Sep;55(3):774-9
references: 1696620
references: Am J Med Genet. 1999 Dec 15;88(6):705-9
references: 10581493
references: Clin Genet. 2001 Aug;60(2):107-16
references: 11553044
references: BMC Genet. 2005 Jun 28;6:39
references: 15985158
references: J Exp Zool B Mol Dev Evol. 2007 May 15;308(3):242-9
references: 17171696
references: Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):379-82
references: 17171657